Other products in the same Health Canada class (J01C, J01CA) — coverage varies; not interchangeable
Ampicillin (Penbritin): general benefit, Not a benefit
Cloxacillin (Orbenin): general benefit, Not a benefit
Penicillin v (Nadopen-V): general benefit, Not a benefit
Piperacillin + tazobactam (Tazocin): not a benefit
Apo-Amoxi · DIN 00628131 · 25mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Amoxi · DIN 00628131
Manufacturer: Apotex Inc.; listing date 1996-10-01
Daily cost (source): $0.3705
Health Canada: Marketed since 2020-06-08 · brand APO-AMOXI · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 125 MG/5ML · company Apotex inc · schedule Prescription
Apo-Amoxi: Formulary list price $0.0247/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0247 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5824 · Verify on the e-Formulary ↗ (DIN 00628131)
Source record
DIN 00628131: Apo-Amoxi
Raw flags: sec3=Y
Item: 081216038; group id 25; item number 0045; lccId None; manufacturer id APX
Source form: O/L; strength: 25mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0247; ministry $0.0247
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00628131
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5824Interchangeable products
Amoxil · DIN 02041316 · not recorded
Auro-Amoxicillin · DIN 02458586 · $0.0247
Jamp-Amoxicillin · DIN 02535793 · $0.0247
Shortage status: resolved shortage (ended 2025-09-11); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00628131
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Auro-Amoxicillin · DIN 02458586 · 25mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Amoxicillin · DIN 02458586
Manufacturer: Auro Pharma Inc.; listing date 2026-07-31
Daily cost (source): $0.3705
Health Canada: Marketed since 2021-10-14 · brand AURO-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 125 MG/5ML · company Auro pharma inc · schedule Prescription
Auro-Amoxicillin: Formulary list price $0.0247/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0247 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94573 · Verify on the e-Formulary ↗ (DIN 02458586)
Source record
DIN 02458586: Auro-Amoxicillin
Raw flags: sec3=Y
Item: 081216038; group id 25; item number 0045; lccId None; manufacturer id AUR
Source form: O/L; strength: 25mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0247; ministry $0.0247
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02458586
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94573Interchangeable products
Amoxil · DIN 02041316 · not recorded
Apo-Amoxi · DIN 00628131 · $0.0247
Jamp-Amoxicillin · DIN 02535793 · $0.0247
Shortage status: resolved shortage (ended 2023-11-17); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02458586
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Jamp-Amoxicillin · DIN 02535793 · 25mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Amoxicillin · DIN 02535793
Manufacturer: Jamp Pharma Corporation; listing date 2023-07-31
Daily cost (source): $0.3705
Health Canada: Marketed since 2023-04-17 · brand JAMP-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 125 MG/5ML · company Jamp pharma corporation · schedule Prescription
Jamp-Amoxicillin: Formulary list price $0.0247/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0247 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102462 · Verify on the e-Formulary ↗ (DIN 02535793)
Source record
DIN 02535793: Jamp-Amoxicillin
Raw flags: sec3=Y
Item: 081216038; group id 25; item number 0045; lccId None; manufacturer id JPC
Source form: O/L; strength: 25mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0247; ministry $0.0247
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02535793
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102462Interchangeable products
Amoxil · DIN 02041316 · not recorded
Apo-Amoxi · DIN 00628131 · $0.0247
Auro-Amoxicillin · DIN 02458586 · $0.0247
Shortage status: active shortage (reported 2026-06-30, estimated to end 2026-09-04, last updated 2026-07-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02535793
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Amoxicillin · DIN 02352753 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Amoxicillin · DIN 02352753
Manufacturer: Sanis Health Inc.; listing date 2020-08-28
Daily cost (source): $0.8100
Health Canada: Marketed since 2013-10-03 · brand AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Granules for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Sanis health inc · schedule Prescription
Amoxicillin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83801 · Verify on the e-Formulary ↗ (DIN 02352753)
Source record
DIN 02352753: Amoxicillin
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id SAI
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02352753
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83801Interchangeable products
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2024-04-22); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02352753
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Amoxicillin · DIN 02401541 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Amoxicillin · DIN 02401541
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2020-08-28
Daily cost (source): $0.8100
Health Canada: Marketed since 2013-02-14 · brand AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Granules for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Sivem pharmaceuticals ulc · schedule Prescription
Amoxicillin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88644 · Verify on the e-Formulary ↗ (DIN 02401541)
Source record
DIN 02401541: Amoxicillin
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id SIV
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02401541
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88644Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2023-02-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02401541
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Amoxicillin (Sugar Reduced) · DIN 02352788
Manufacturer: Sanis Health Inc.; listing date 2020-10-30
Daily cost (source): $0.8100
Health Canada: Marketed since 2013-10-03 · brand AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Granules for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Sanis health inc · schedule Prescription
Amoxicillin (Sugar Reduced): Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83803 · Verify on the e-Formulary ↗ (DIN 02352788)
Source record
DIN 02352788: Amoxicillin (Sugar Reduced)
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id SAI
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02352788
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83803Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2023-07-14); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02352788
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Apo-Amoxi · DIN 00628158 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Amoxi · DIN 00628158
Manufacturer: Apotex Inc.; listing date 1996-10-01
Daily cost (source): $0.8100
Health Canada: Marketed since 2020-06-08 · brand APO-AMOXI · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Apotex inc · schedule Prescription
Apo-Amoxi: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5825 · Verify on the e-Formulary ↗ (DIN 00628158)
Source record
DIN 00628158: Apo-Amoxi
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id APX
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00628158
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5825Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2025-06-19); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00628158
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Auro-Amoxicillin · DIN 02458594 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Amoxicillin · DIN 02458594
Manufacturer: Auro Pharma Inc.; listing date 2023-11-30
Daily cost (source): $0.8100
Health Canada: Marketed since 2021-10-14 · brand AURO-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Auro pharma inc · schedule Prescription
Auro-Amoxicillin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94574 · Verify on the e-Formulary ↗ (DIN 02458594)
Source record
DIN 02458594: Auro-Amoxicillin
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id AUR
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02458594
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94574Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2025-07-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02458594
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Jamp-Amoxicillin · DIN 02535815 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Amoxicillin · DIN 02535815
Manufacturer: Jamp Pharma Corporation; listing date 2023-08-31
Daily cost (source): $0.8100
Health Canada: Marketed since 2023-04-18 · brand JAMP-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Jamp pharma corporation · schedule Prescription
Jamp-Amoxicillin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102464 · Verify on the e-Formulary ↗ (DIN 02535815)
Source record
DIN 02535815: Jamp-Amoxicillin
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id JPC
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02535815
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102464Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: active shortage (reported 2026-05-12, estimated to end 2026-09-04, last updated 2026-07-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02535815
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Novamoxin · DIN 00452130 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novamoxin · DIN 00452130
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Daily cost (source): $0.8100
Health Canada: Marketed since 2013-06-04 · brand NOVAMOXIN · ATC J01CA04 AMOXICILLIN · form Granules for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Teva canada limited · schedule Prescription
Novamoxin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3344 · Verify on the e-Formulary ↗ (DIN 00452130)
Source record
DIN 00452130: Novamoxin
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id TEV
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00452130
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3344Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2026-04-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00452130
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novamoxin (Sugar Reduced) · DIN 01934163
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Daily cost (source): $0.8100
Health Canada: Marketed since 2013-06-04 · brand NOVAMOXIN · ATC J01CA04 AMOXICILLIN · form Granules for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Teva canada limited · schedule Prescription
Novamoxin (Sugar Reduced): Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16954 · Verify on the e-Formulary ↗ (DIN 01934163)
Source record
DIN 01934163: Novamoxin (Sugar Reduced)
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id TEV
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01934163
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16954Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Sandoz Amoxicillin · DIN 02495864 · $0.0540
Shortage status: resolved shortage (ended 2023-07-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01934163
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Sandoz Amoxicillin · DIN 02495864 · 50mg/mL · oral liquid
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Amoxicillin · DIN 02495864
Manufacturer: Sandoz Canada Inc.; listing date 2024-06-28
Daily cost (source): $0.8100
Health Canada: Marketed since 2024-04-29 · brand SANDOZ AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Powder for suspension · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG/5ML · company Sandoz canada incorporated · schedule Prescription
Sandoz Amoxicillin: Formulary list price $0.0540/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0540 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98576 · Verify on the e-Formulary ↗ (DIN 02495864)
Source record
DIN 02495864: Sandoz Amoxicillin
Raw flags: sec3=Y
Item: 081216037; group id 25; item number 0046; lccId None; manufacturer id SDZ
Source form: O/L; strength: 50mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.0540; ministry $0.0540
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02495864
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98576Interchangeable products
Amoxicillin · DIN 02352753 · $0.0540
Amoxicillin · DIN 02401541 · $0.0540
Amoxicillin (Sugar Reduced) · DIN 02352788 · $0.0540
Amoxil · DIN 02042592 · not recorded
Apo-Amoxi · DIN 00628158 · $0.0540
Auro-Amoxicillin · DIN 02458594 · $0.0540
Jamp-Amoxicillin · DIN 02535815 · $0.0540
Novamoxin · DIN 00452130 · $0.0540
Novamoxin (Sugar Reduced) · DIN 01934163 · $0.0540
Shortage status: resolved shortage (ended 2026-05-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02495864
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Amoxicillin Capsules BP · DIN 02525348 · 250mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Amoxicillin Capsules BP · DIN 02525348
Manufacturer: Sanis Health Inc.; listing date 2023-01-31
Daily cost (source): $0.2016
Health Canada: Marketed since 2022-11-03 · brand AMOXICILLIN CAPSULES BP · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Sanis health inc · schedule Prescription
Amoxicillin Capsules BP: Formulary list price $0.0672/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0672 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101436 · Verify on the e-Formulary ↗ (DIN 02525348)
Source record
DIN 02525348: Amoxicillin Capsules BP
Raw flags: sec3=Y
Item: 081216036; group id 25; item number 0041; lccId None; manufacturer id SAI
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.0672; ministry $0.0672
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02525348
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101436Interchangeable products
Amoxil · DIN 02041294 · not recorded
Apo-Amoxi · DIN 00628115 · $0.0672
Auro-Amoxicillin · DIN 02388073 · $0.0672
Jamp-Amoxicillin · DIN 02433060 · $0.0672
Novamoxin · DIN 00406724 · $0.0672
PRZ-Amoxicillin · DIN 02532042 · $0.0672
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02525348
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Apo-Amoxi · DIN 00628115 · 250mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Amoxi · DIN 00628115
Manufacturer: Apotex Inc.; listing date 1996-10-01
Daily cost (source): $0.2016
Health Canada: Marketed since 2019-10-30 · brand APO-AMOXI · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Apotex inc · schedule Prescription
Apo-Amoxi: Formulary list price $0.0672/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0672 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5822 · Verify on the e-Formulary ↗ (DIN 00628115)
Source record
DIN 00628115: Apo-Amoxi
Raw flags: sec3=Y
Item: 081216036; group id 25; item number 0041; lccId None; manufacturer id APX
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.0672; ministry $0.0672
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00628115
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5822Interchangeable products
Amoxicillin Capsules BP · DIN 02525348 · $0.0672
Amoxil · DIN 02041294 · not recorded
Auro-Amoxicillin · DIN 02388073 · $0.0672
Jamp-Amoxicillin · DIN 02433060 · $0.0672
Novamoxin · DIN 00406724 · $0.0672
PRZ-Amoxicillin · DIN 02532042 · $0.0672
Shortage status: resolved shortage (ended 2023-04-13); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00628115
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Auro-Amoxicillin · DIN 02388073 · 250mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Amoxicillin · DIN 02388073
Manufacturer: Auro Pharma Inc.; listing date 2012-12-21
Daily cost (source): $0.2016
Health Canada: Marketed since 2012-07-26 · brand AURO-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Auro pharma inc · schedule Prescription
Auro-Amoxicillin: Formulary list price $0.0672/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0672 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87364 · Verify on the e-Formulary ↗ (DIN 02388073)
Source record
DIN 02388073: Auro-Amoxicillin
Raw flags: sec3=Y
Item: 081216036; group id 25; item number 0041; lccId None; manufacturer id AUR
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.0672; ministry $0.0672
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02388073
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87364Interchangeable products
Amoxicillin Capsules BP · DIN 02525348 · $0.0672
Amoxil · DIN 02041294 · not recorded
Apo-Amoxi · DIN 00628115 · $0.0672
Jamp-Amoxicillin · DIN 02433060 · $0.0672
Novamoxin · DIN 00406724 · $0.0672
PRZ-Amoxicillin · DIN 02532042 · $0.0672
Shortage status: resolved shortage (ended 2024-04-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02388073
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Jamp-Amoxicillin · DIN 02433060 · 250mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Amoxicillin · DIN 02433060
Manufacturer: Jamp Pharma Corporation; listing date 2019-03-28
Daily cost (source): $0.2016
Health Canada: Marketed since 2015-12-07 · brand JAMP-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Jamp pharma corporation · schedule Prescription
Jamp-Amoxicillin: Formulary list price $0.0672/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0672 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91747 · Verify on the e-Formulary ↗ (DIN 02433060)
Source record
DIN 02433060: Jamp-Amoxicillin
Raw flags: sec3=Y
Item: 081216036; group id 25; item number 0041; lccId None; manufacturer id JPC
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.0672; ministry $0.0672
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02433060
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91747Interchangeable products
Amoxicillin Capsules BP · DIN 02525348 · $0.0672
Amoxil · DIN 02041294 · not recorded
Apo-Amoxi · DIN 00628115 · $0.0672
Auro-Amoxicillin · DIN 02388073 · $0.0672
Novamoxin · DIN 00406724 · $0.0672
PRZ-Amoxicillin · DIN 02532042 · $0.0672
Shortage status: resolved shortage (ended 2023-05-01); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02433060
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Novamoxin · DIN 00406724 · 250mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novamoxin · DIN 00406724
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Daily cost (source): $0.2016
Health Canada: Marketed since 2013-06-04 · brand NOVAMOXIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Teva canada limited · schedule Prescription
Novamoxin: Formulary list price $0.0672/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0672 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3264 · Verify on the e-Formulary ↗ (DIN 00406724)
Source record
DIN 00406724: Novamoxin
Raw flags: sec3=Y
Item: 081216036; group id 25; item number 0041; lccId None; manufacturer id TEV
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.0672; ministry $0.0672
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00406724
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3264Interchangeable products
Amoxicillin Capsules BP · DIN 02525348 · $0.0672
Amoxil · DIN 02041294 · not recorded
Apo-Amoxi · DIN 00628115 · $0.0672
Auro-Amoxicillin · DIN 02388073 · $0.0672
Jamp-Amoxicillin · DIN 02433060 · $0.0672
PRZ-Amoxicillin · DIN 02532042 · $0.0672
Shortage status: resolved shortage (ended 2023-06-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00406724
Shortage record checked 2026-09-13T08:10:21.292534+00:00
PRZ-Amoxicillin · DIN 02532042 · 250mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PRZ-Amoxicillin · DIN 02532042
Manufacturer: Pharmaris Canada Inc.; listing date 2024-03-28
Daily cost (source): $0.2016
Health Canada: Marketed since 2023-12-22 · brand PRZ-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Pharmaris canada inc · schedule Prescription
PRZ-Amoxicillin: Formulary list price $0.0672/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.0672 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102111 · Verify on the e-Formulary ↗ (DIN 02532042)
Source record
DIN 02532042: PRZ-Amoxicillin
Raw flags: sec3=Y
Item: 081216036; group id 25; item number 0041; lccId None; manufacturer id PRZ
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.0672; ministry $0.0672
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02532042
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102111Interchangeable products
Amoxicillin Capsules BP · DIN 02525348 · $0.0672
Amoxil · DIN 02041294 · not recorded
Apo-Amoxi · DIN 00628115 · $0.0672
Auro-Amoxicillin · DIN 02388073 · $0.0672
Jamp-Amoxicillin · DIN 02433060 · $0.0672
Novamoxin · DIN 00406724 · $0.0672
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02532042
Shortage record checked 2026-09-13T08:10:21.292534+00:00
AG-Amoxicillin · DIN 02477726 · 500mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AG-Amoxicillin · DIN 02477726
Manufacturer: Angita Pharma Inc.; listing date 2020-12-18
Daily cost (source): $0.3924
Health Canada: Marketed since 2018-09-06 · brand AG-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500 MG · company Angita pharma inc. · schedule Prescription
AG-Amoxicillin: Formulary list price $0.1308/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.1308 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96865 · Verify on the e-Formulary ↗ (DIN 02477726)
Source record
DIN 02477726: AG-Amoxicillin
Raw flags: sec3=Y
Item: 081216039; group id 25; item number 0042; lccId None; manufacturer id ANG
Source form: Cap; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.1308; ministry $0.1308
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02477726
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96865Interchangeable products
Amoxicillin · DIN 02401509 · $0.1308
Amoxicillin Capsules BP · DIN 02525356 · $0.1308
Amoxil · DIN 02041308 · not recorded
Apo-Amoxi · DIN 00628123 · $0.1308
Auro-Amoxicillin · DIN 02388081 · $0.1308
Jamp-Amoxicillin · DIN 02433079 · $0.1308
NRA-Amoxicillin · DIN 02561417 · $0.1308
Novamoxin · DIN 00406716 · $0.1308
PRZ-Amoxicillin · DIN 02532050 · $0.1308
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02477726
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Amoxicillin · DIN 02401509 · 500mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Amoxicillin · DIN 02401509
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2020-12-18
Daily cost (source): $0.3924
Health Canada: Marketed since 2020-10-31 · brand AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Amoxicillin: Formulary list price $0.1308/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.1308 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88640 · Verify on the e-Formulary ↗ (DIN 02401509)
Source record
DIN 02401509: Amoxicillin
Raw flags: sec3=Y
Item: 081216039; group id 25; item number 0042; lccId None; manufacturer id SIV
Source form: Cap; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.1308; ministry $0.1308
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02401509
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88640Interchangeable products
AG-Amoxicillin · DIN 02477726 · $0.1308
Amoxicillin Capsules BP · DIN 02525356 · $0.1308
Amoxil · DIN 02041308 · not recorded
Apo-Amoxi · DIN 00628123 · $0.1308
Auro-Amoxicillin · DIN 02388081 · $0.1308
Jamp-Amoxicillin · DIN 02433079 · $0.1308
NRA-Amoxicillin · DIN 02561417 · $0.1308
Novamoxin · DIN 00406716 · $0.1308
PRZ-Amoxicillin · DIN 02532050 · $0.1308
Shortage status: resolved shortage (ended 2017-07-16); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02401509
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Amoxicillin Capsules BP · DIN 02525356 · 500mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Amoxicillin Capsules BP · DIN 02525356
Manufacturer: Sanis Health Inc.; listing date 2023-01-31
Daily cost (source): $0.3924
Health Canada: Marketed since 2022-11-03 · brand AMOXICILLIN CAPSULES BP · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500 MG · company Sanis health inc · schedule Prescription
Amoxicillin Capsules BP: Formulary list price $0.1308/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.1308 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101437 · Verify on the e-Formulary ↗ (DIN 02525356)
Source record
DIN 02525356: Amoxicillin Capsules BP
Raw flags: sec3=Y
Item: 081216039; group id 25; item number 0042; lccId None; manufacturer id SAI
Source form: Cap; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.1308; ministry $0.1308
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02525356
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101437Interchangeable products
AG-Amoxicillin · DIN 02477726 · $0.1308
Amoxicillin · DIN 02401509 · $0.1308
Amoxil · DIN 02041308 · not recorded
Apo-Amoxi · DIN 00628123 · $0.1308
Auro-Amoxicillin · DIN 02388081 · $0.1308
Jamp-Amoxicillin · DIN 02433079 · $0.1308
NRA-Amoxicillin · DIN 02561417 · $0.1308
Novamoxin · DIN 00406716 · $0.1308
PRZ-Amoxicillin · DIN 02532050 · $0.1308
Shortage status: resolved shortage (ended 2024-11-11); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02525356
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Apo-Amoxi · DIN 00628123 · 500mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Amoxi · DIN 00628123
Manufacturer: Apotex Inc.; listing date 1996-10-01
Daily cost (source): $0.3924
Health Canada: Marketed since 2019-10-30 · brand APO-AMOXI · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500 MG · company Apotex inc · schedule Prescription
Apo-Amoxi: Formulary list price $0.1308/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.1308 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5823 · Verify on the e-Formulary ↗ (DIN 00628123)
Source record
DIN 00628123: Apo-Amoxi
Raw flags: sec3=Y
Item: 081216039; group id 25; item number 0042; lccId None; manufacturer id APX
Source form: Cap; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.1308; ministry $0.1308
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00628123
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5823Interchangeable products
AG-Amoxicillin · DIN 02477726 · $0.1308
Amoxicillin · DIN 02401509 · $0.1308
Amoxicillin Capsules BP · DIN 02525356 · $0.1308
Amoxil · DIN 02041308 · not recorded
Auro-Amoxicillin · DIN 02388081 · $0.1308
Jamp-Amoxicillin · DIN 02433079 · $0.1308
NRA-Amoxicillin · DIN 02561417 · $0.1308
Novamoxin · DIN 00406716 · $0.1308
PRZ-Amoxicillin · DIN 02532050 · $0.1308
Shortage status: resolved shortage (ended 2025-01-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00628123
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Auro-Amoxicillin · DIN 02388081 · 500mg · capsule
General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Amoxicillin · DIN 02388081
Manufacturer: Auro Pharma Inc.; listing date 2012-12-21
Daily cost (source): $0.3924
Health Canada: Marketed since 2012-07-26 · brand AURO-AMOXICILLIN · ATC J01CA04 AMOXICILLIN · form Capsule · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500 MG · company Auro pharma inc · schedule Prescription
Auro-Amoxicillin: Formulary list price $0.1308/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.1308 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87365 · Verify on the e-Formulary ↗ (DIN 02388081)
Source record
DIN 02388081: Auro-Amoxicillin
Raw flags: sec3=Y
Item: 081216039; group id 25; item number 0042; lccId None; manufacturer id AUR
Source form: Cap; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.1308; ministry $0.1308
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02388081
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87365Interchangeable products
AG-Amoxicillin · DIN 02477726 · $0.1308
Amoxicillin · DIN 02401509 · $0.1308
Amoxicillin Capsules BP · DIN 02525356 · $0.1308
Amoxil · DIN 02041308 · not recorded
Apo-Amoxi · DIN 00628123 · $0.1308
Jamp-Amoxicillin · DIN 02433079 · $0.1308
NRA-Amoxicillin · DIN 02561417 · $0.1308
Novamoxin · DIN 00406716 · $0.1308
PRZ-Amoxicillin · DIN 02532050 · $0.1308
Shortage status: resolved shortage (ended 2022-04-06); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02388081
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Novamoxin Chewable · DIN 02036355 · 250mg · chewable tablet
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Special Drugs ProgramSpecial Drugs Program: Amoxicillin, ascorbic acid (Vitamin C), deferoxamine, folic acid, hydrocortisone injection, penicillin and trimethoprim/sulfamethoxazole for the treatment of thalassaemia (ontario.ca, Updated 2023-07-13 ↗)
Through the Special Drugs Program, the Ministry of Health covers the full cost of certain outpatient drugs used in the treatment of specific conditions. (ontario.ca, Updated 2023-07-13 ↗)
The Special Drugs Program will cover costs for the above drugs if the patient:
is an Ontario resident
has a valid Ontario Health Insurance (OHIP)
has one of the diseases or conditions covered
meets the established clinical criteria
is under the care of an approved physician/designated care centre (ontario.ca, Updated 2023-07-13 ↗)
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Novamoxin Chewable · DIN 02036355
Manufacturer: Teva Canada Limited; listing date 2008-11-04
Health Canada: Marketed since 2013-06-04 · brand NOVAMOXIN · ATC J01CA04 AMOXICILLIN · form Tablet (chewable) · route Oral · ingredients AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 250 MG · company Teva canada limited · schedule Prescription
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14506 · Verify on the e-Formulary ↗ (DIN 02036355)
Source record
DIN 02036355: Novamoxin Chewable
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 081216091; group id 25; item number 0044; lccId None; manufacturer id TEV
Source form: Chew Tab; strength: 250mg
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $0.8282; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02036355
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14506Interchangeable products
Amoxil Chewable · DIN 02041286 · not recorded
Shortage status: resolved shortage (ended 2025-07-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02036355
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary classes and how they are covered
Other drugs in the same formulary class (08:12:16 Penicillins) and how they are covered
Matched class: 08:12:16 Penicillins
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Some products covered without a code (check the product listing): AMPICILLIN, CLOXACILLIN, PENICILLIN V (POTASSIUM)
08:12:16 Penicillins
Other drugs in the same formulary class (56:40 Miscellaneous G.I. Drugs) and how they are covered
Matched class: 56:40 Miscellaneous G.I. Drugs
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: BUDESONIDE, MESALAZINE, NIZATIDINE, OLSALAZINE SODIUM, PANTOPRAZOLE MAGNESIUM, RABEPRAZOLE SODIUM, SUCRALFATE
Some products covered without a code (check the product listing): 5-AMINOSALICYLIC ACID, CIMETIDINE, DOMPERIDONE MALEATE, FAMOTIDINE, LACTULOSE, METOCLOPRAMIDE HCL, MISOPROSTOL, RANITIDINE HCL
56:40 Miscellaneous G.I. Drugs
· 6 products · General benefit · strengths: 40mg · Ent Coated Tab
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 56:40
and 10 more
From Health Canada product monographs; label wording only, not a treatment recommendation.
Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ.
No displayed matched alternative is a general benefit.
CEFOXITIN SODIUM · Off-Formulary Interchangeable, not an ODB benefit
5 - Lower respiratory tract infections
PM: https://pdf.hres.ca/dpd_pm/00073366.PDF; date November 16, 2023; DIN 02128187; fetched 2026-09-10
Product monographCEFTRIAXONE DISODIUM · Listed, not a benefit (3), General benefit (10), Off-Formulary Interchangeable, not an ODB benefit (3)
• Lower Respiratory tract infections caused by E. coli, H. influenzae, K. pneumoniae and species,
Staph. aureus, Strep. pneumoniae and species (excluding enterococci).
PM: https://pdf.hres.ca/dpd_pm/00071552.PDF; date MAY 15, 2023; DIN 02289695; fetched 2026-09-10
Product monograph
Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
1 INDICATIONS
Novamoxin (amoxicillin) may be indicated in the treatment of infections due to susceptible strains of the
following micro-organisms: Gram-negative organisms: H. influenzae, P. mirabilis and N. gonorrhoeae.
Gram-positive organisms: Streptococci (including Streptococcus faecalis and Streptococcus pneumoniae).
Amoxicillin is not active against Pseudomonas aeruginosa, indole-positive Proteus species, Serratia
marcescens, Klebsiella and Enterobacter species.
In emergency cases, where the causative organism is not yet identified, therapy may be initiated with
amoxicillin on the basis of clinical judgment while awaiting bacteriologic tests to determine its
antimicrobial sensitivity.
Novamoxin may be indicated as a prophylaxis against alpha-hemolytic (Viridan's group) Streptococci
before dental, oral or upper respiratory tract surgery or instrumentation.
It may be also indicated as a prophylaxis of bacterial endocarditis in patients with any of the following
conditions: congenital cardiac malformations, rheumatic and other acquired valvular lesions, prosthetic
heart valves, previous history of bacterial endocarditis, hypertrophic cardiomyopathy, surgically
constr…
https://pdf.hres.ca/dpd_pm/00080491.PDF
PM date: February 9, 1979
Source product: NOVAMOXIN; DIN 00406716; fetched 2026-09-10
Product monograph posted by Health Canada; excerpt for lookup only.
What the Health Canada label says it is for
1. Indications
CLAVULIN (amoxicillin / clavulanate potassium) is indicated for the treatment of the following
infections when caused by CLAVULIN-susceptible strains of the designated bacteria:
• Sinusitis when caused by β-lactamase producing strains of H. influenzae or Moraxella
(Branhamella) catarrhalis.
• Otitis Media when caused by β-lactamase producing strains of H. influenzae or Moraxella
(Branhamella) catarrhalis.
• Lower Respiratory Tract Infections when caused by β-lactamase producing strains of H. influenzae,
K. pneumoniae, S. aureus or Moraxella (Branhamella) catarrhalis.
• Skin and Soft Tissue Infections when caused by β-lactamase producing strains of S. aureus.
• Urinary Tract Infections when caused by β-lactamase producing strains of E. coli.
While CLAVULIN is indicated only for the conditions listed above, infections caused by ampicillin
(amoxicillin) susceptible organisms are also amenable to CLAVULIN treatment due to its amoxicillin
content. Furthermore, mixed infections caused by organisms susceptible to ampicillin (amoxicillin) and
β-lactamase producing organisms susceptible to CLAVULIN should not require the addition of another
an…
https://pdf.hres.ca/dpd_pm/00084428.PDF
PM date: 2026-04-24
Source product: CLAVULIN 250 F ORAL SUS; DIN 01916874; fetched 2026-09-10
Product monograph posted by Health Canada; excerpt for lookup only.
What the Health Canada label says it is for
1 INDICATIONS
The components of the AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN [lansoprazole
delayed-release capsules, in combination with clarithromycin tablets plus amoxicillin capsules
as triple therapy], are indicated for:
● the treatment of patients with Helicobacter pylori (H. pylori) infection and active
duodenal ulcer disease. Eradication of H. pylori has been shown to reduce the risk of
duodenal ulcer recurrence (see 14.1 Clinical Trials by Indication and 4 DOSAGE AND
ADMINISTRATION).
In patients with a recent history of duodenal ulcers who are H. pylori positive, eradication
therapy may reduce the rate of recurrence of duodenal ulcers. The optimal timing for
eradication therapy for such patients remains to be determined.
In patients who fail a therapy combination containing clarithromycin, susceptibility testing
should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not
possible, an alternative therapy combination is recommended. Resistance to amoxicillin has not
been demonstrated in clinical studies with lansoprazole delayed-release capsules and
amoxicillin.
Table 1 summarizes the eradication rates for th…
https://pdf.hres.ca/dpd_pm/00077480.PDF
PM date: OCT 18, 2024
Source product: AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN; DIN 02470780; fetched 2026-09-10
Product monograph posted by Health Canada; excerpt for lookup only.
Availability
Jamp-Amoxicillin · DIN 02535793
Shortage status: active shortage (reported 2026-06-30, estimated to end 2026-09-04, last updated 2026-07-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02535793
Jamp-Amoxicillin · DIN 02535815
Shortage status: active shortage (reported 2026-05-12, estimated to end 2026-09-04, last updated 2026-07-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02535815
For Novamoxin Chewable: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.
For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy
Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.
For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)
Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.